Wang, Virginia
Zepel, Lindsay
Diamantidis, Clarissa J.
Smith, Valerie A.
Scholle, Sarah Hudson
Maciejewski, Matthew L.
Funding for this research was provided by:
Centers for Medicare and Medicaid Services (HHSM-500-2014-00442G, HHSM-500-2014-00442G, HHSM-500-2014-00442G, HHSM-500-2014-00442G, HHSM-500-2014-00442G, HHSM-500-2014-00442G)
Article History
Received: 5 November 2020
Accepted: 20 April 2021
First Online: 5 May 2021
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations.All experimental protocols were approved by Duke University. Waiver of informed consent was obtained by the Duke IRB.
: N/A.
: The coauthors reported receiving institutional grants from the Department of Veterans Affairs HSR&D (MLM, VW, VS), the Agency for Healthcare Research and Quality (MLM, VW), the National Institute for Drug Abuse (MLM, VS) the National Institute of Diabetes and Digestive and Kidney Diseases (CJD, MLM, VW), the National Cancer Institute (MLM), and an institutional contract from the Centers for Medicare and Medicaid Services (MLM, VW, VS). Dr. Maciejewski reported ownership of Amgen stock due to his spouse’s employment. All the other authors declare no conflict of interests.